Terms: = Leukemia AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610
94 results:
1. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
2. [Clinical and laboratory features of SF3B1-mutated myeloproliferative neoplasms].
Peng L; Zhang YH; Teng GS; Du CX; Wang Y; Hu NB; Li YQ; Shao ZH; Bai J
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(43):3472-3477. PubMed ID: 37981774
[No Abstract] [Full Text] [Related]
3. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
[TBL] [Abstract] [Full Text] [Related]
4. ZNF384-Related Fusion Genes in Acute Lymphoblastic leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
5. Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia.
Chen LY; Gong WJ; Li MH; Zhou HX; Xu MZ; Qian CS; Kang LQ; Xu N; Yu Z; Qiao M; Zhang TT; Zhang L; Tian ZL; Sun AN; Yu L; Wu DP; Xue SL
Blood Adv; 2023 Sep; 7(17):4913-4925. PubMed ID: 36897251
[TBL] [Abstract] [Full Text] [Related]
6. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.
Tsai XC; Sun KJ; Lo MY; Tien FM; Kuo YY; Tseng MH; Peng YL; Chuang YK; Ko BS; Tang JL; Sun HI; Liu MC; Liu CW; Lin CC; Yao M; Chou WC; Hou HA; Tien HF
Blood Cancer J; 2023 Jan; 13(1):4. PubMed ID: 36599822
[TBL] [Abstract] [Full Text] [Related]
7. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract] [Full Text] [Related]
8. Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
Salama Y; Zhao F; Oliveira JL; Yuan J; Jevremovic D; Go RS; Ding W; Parikh SA; Shah MV; Hampel PJ; Al-Kali A; Morice WG; Shi M
Blood Cancer J; 2022 Feb; 12(2):30. PubMed ID: 35194022
[TBL] [Abstract] [Full Text] [Related]
9. Invasive Fungal Infections in Children with leukemia: Clinical Features and Prognosis.
Sezgin Evim M; Tüfekçi Ö; Baytan B; Ören H; Çelebi S; Ener B; Üstün Elmas K; Yılmaz Ş; Erdem M; Hacımustafaoğlu MK; Güneş AM
Turk J Haematol; 2022 Jun; 39(2):94-102. PubMed ID: 34792308
[TBL] [Abstract] [Full Text] [Related]
10. A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring.
Bernasconi DP; Antolini L; Rossi E; Blanco-Lopez JG; Galimberti S; Andersen PK; Valsecchi MG
Int J Epidemiol; 2022 Feb; 51(1):314-323. PubMed ID: 34368848
[TBL] [Abstract] [Full Text] [Related]
11. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract] [Full Text] [Related]
12. Frequent loss of CD10 expression in follicular lymphoma with leukaemic presentation.
Chen SW; Chang ST; Hsieh YC; Kuo CC; Wu HC; Feng YH; Chuang SS
Malays J Pathol; 2020 Aug; 42(2):237-243. PubMed ID: 32860376
[TBL] [Abstract] [Full Text] [Related]
13. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract] [Full Text] [Related]
14. Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
Schischlik F; Jäger R; Rosebrock F; Hug E; Schuster M; Holly R; Fuchs E; Milosevic Feenstra JD; Bogner E; Gisslinger B; Schalling M; Rumi E; Pietra D; Fischer G; Faé I; Vulliard L; Menche J; Haferlach T; Meggendorfer M; Stengel A; Bock C; Cazzola M; Gisslinger H; Kralovics R
Blood; 2019 Jul; 134(2):199-210. PubMed ID: 31064751
[TBL] [Abstract] [Full Text] [Related]
15. Chemical constituents of Patrinia heterophylla Bunge and selective cytotoxicity against six human tumor cells.
Sheng L; Yang Y; Zhang Y; Li N
J Ethnopharmacol; 2019 May; 236():129-135. PubMed ID: 30853646
[TBL] [Abstract] [Full Text] [Related]
16. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
[TBL] [Abstract] [Full Text] [Related]
17. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract] [Full Text] [Related]
18. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.
Arends CM; Galan-Sousa J; Hoyer K; Chan W; Jäger M; Yoshida K; Seemann R; Noerenberg D; Waldhueter N; Fleischer-Notter H; Christen F; Schmitt CA; Dörken B; Pelzer U; Sinn M; Zemojtel T; Ogawa S; Märdian S; Schreiber A; Kunitz A; Krüger U; Bullinger L; Mylonas E; Frick M; Damm F
Leukemia; 2018 Sep; 32(9):1908-1919. PubMed ID: 29491455
[TBL] [Abstract] [Full Text] [Related]
19. Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Dragoun M; Günther T; Frias C; Berkessel A; Prokop A
J Cancer Res Clin Oncol; 2018 Apr; 144(4):685-695. PubMed ID: 29374786
[TBL] [Abstract] [Full Text] [Related]
20. Haploidentical hematopoietic SCT using helical tomotherapy for total-body irradiation and targeted dose boost in patients with high-risk/refractory acute lymphoblastic leukemia.
Jiang Z; Jia J; Yue C; Pang Y; Liu Z; Ouyang L; Li H; Zhang J; Wen T; Li J; Li Z; Wang Y; Xiao Y; Xiao H
Bone Marrow Transplant; 2018 Apr; 53(4):438-448. PubMed ID: 29330392
[TBL] [Abstract] [Full Text] [Related]
[Next]
